Dose of Reality: I-MAK Report Outlines How Big Pharma Extends Monopolies to Keep Drug Prices High
Apr 24, 2026
Analysis Demonstrates Tremendous Cost of Anti-Competitive Tactics Like Patent… Read More
© 2026 CSRXP- All Rights Reserved
Blog Posts
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Apr 23, 2026
Johnson & Johnson Beats Profit Expectations, Lifts Forecast Following… Read More
BIRDS OF A FEATHER: BIG PHARMA M&A SPLURGE BRINGS TOGETHER DRUG COMPANIES WITH SHARED TRACK RECORD OF PRICE HIKES OUTPACING INFLATION
Apr 14, 2026
Big Pharma Giants Acquire New Blockbuster Products with Existing History of… Read More
THEY SAID IT! U.S. SENATORS URGE FDA TO FURTHER CRACK DOWN ON BIG PHARMA’S DTC ADVERTISING
Apr 13, 2026
Bipartisan Letter Targets Big Pharma’s Misleading Ads That Inflate Costs And… Read More
THEY SAID IT! HHS OFFICIAL: “COMPETITION IS AN INCREDIBLY EFFECTIVE TOOL TO ADDRESS HIGH DRUG PRICES”
Mar 27, 2026
Administration Touts Positive Steps to Bring More Biosimilars to Market… Read More
DOSE OF REALITY: GSK’S BRAND NAME INHALER BAIT-AND-SWITCH INCREASED COSTS AND WORSENED HEALTH OUTCOMES
Mar 18, 2026
New Report Details Impact of Big Pharma Giant’s Strategy to Maintain… Read More
DOSE OF REALITY: HEALTH AFFAIRS SCHOLAR ANALYSIS FINDS BIG PHARMA’S PATENT ABUSE GROWING IN SCALE, KEEPING PRESCRIPTION DRUG PRICES HIGH
Mar 3, 2026
New Report Demonstrates How Brand Name Drug Companies Wield Litigation Around… Read More
BIG PHARMA EARNINGS WATCH: AMGEN AND BRISTOL MYERS SQUIBB
Feb 13, 2026
Big Pharma Tops Earnings Forecasts After Hiking Drug Prices, Again This month,… Read More
THEY SAID IT! LAWMAKERS AND EXPERTS CALL OUT BIG PHARMA’S ANTI-COMPETITIVE PLAYBOOK, URGE CONGRESS TO BOOST GENERIC AND BIOSIMILAR COMPETITION
Feb 12, 2026
U.S. House Energy & Commerce Health Subcommittee Hearing Puts Big Pharma… Read More
DOSE OF REALITY: LAWMAKERS HAVE OPPORTUNITY TO HOLD BIG PHARMA ACCOUNTABLE FOR EGREGIOUS PRICING AND ANTI-COMPETITIVE PRACTICES DRIVING HEALTH CARE COSTS
Feb 10, 2026
Big Pharma Sets Out-of-Control Launch Prices, Hikes Prices Outpacing… Read More
BIG PHARMA EARNINGS WATCH: ABBVIE, NOVARTIS, GSK AND ELI LILLY
Feb 9, 2026
Big Pharma Companies Beat Wall Street Earnings Expectations Amid Bonanza of… Read More
BIG PHARMA EARNINGS WATCH: PFIZER AND MERCK
Feb 5, 2026
Pfizer and Merck Beat Wall Street Expectations After Hiking Prices to Start… Read More